Clinical evolution

Icon eyeing China

Icon eyeing China

By Nick Taylor

Icon is looking to expand its bioanalytical capacity in Asia, notably in China, and bolster its genomics, proteomics and cell-based assay capabilities, according to a VP who discussed diversification of the business.

Pharma turning to SAAS

Pharma turning to SAAS

By Nick Taylor

Pharma’s increasing collaboration and budget cuts have made hosted software more attractive to companies, according to Symyx which has made its lab notebook available on this platform.

Quintiles inks pharma deals

Quintiles inks pharma deals

By Nick Taylor

Quintiles is continuing to build alliances with large pharmas, inking deals to perform “the majority” of AstraZeneca’s (AZ) clinical pharmacology work and develop six oncology products in Eisai’s pipeline.